4. Krystal, J.H., Tolin, D.F., Sanacora, G., Castner, S.A., Williams, G.V., Aikins, D.E., Hoffman, R.E. and D’Souza, D.C. (2009). Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia, Drug Discovery Today, 14(13-14), 690-697. https://pubmed.ncbi.nlm.nih.gov/19460458/